Trials / Recruiting
RecruitingNCT04490720
The Efficacy Evaluation of Buckwheat Husk Extract on Cardiovascular Disease Risk Factors
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- TCI Co., Ltd. · Industry
- Sex
- All
- Age
- 20 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
To assess the efficacy evaluation of buckwheat husk extract on cardiovascular disease risk factors
Detailed description
This is a double-blind and randomized study. Subjects are informed to consume the samples every day for 2 months. The clinical diagnosis item of cardiovascular disease is evaluated by the doctor.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Placebo | consume 1 sachet per day for 2 months |
| DIETARY_SUPPLEMENT | Buckwheat husk extract | consume 1 sachet per day for 2 months |
Timeline
- Start date
- 2021-11-24
- Primary completion
- 2025-12-31
- Completion
- 2026-02-28
- First posted
- 2020-07-29
- Last updated
- 2025-01-09
Locations
1 site across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT04490720. Inclusion in this directory is not an endorsement.